Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion

Janet Neisewander, Rita A. Fuchs, Laura E. O'Dell, Taline V. Khroyan

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

This study examined the effects of both systemic and intraaccumbens administration of SCH-23390 in rats on dopamine D1 receptor occupancy and on locomotor activity produced by intraaccumbens infusion of cocaine. In experiment 1, rats received SCH-23390 (0-1 mg/kg, IP) 15 minutes prior to intraaccumbens infusion of cocaine (0 or 100 μg/side). In experiment 2, rats received coinfusion of SCH-23390 (0-1 μg/side) and cocaine (0 or 100 μg/side) into the nucleus accumbens (NAc). After behavioral testing, receptors occupied by SCH-23390 were quantified by injecting animals with their respective dose of SCH-23390, followed by a systemic injection of the irreversible antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Receptors occupied by SCH-23390, and therefore protected from EEDQ- induced inactivation, were quantified from autoradiograms of sections labeled with 3H-SCH-23390. Systemic administration of SCH-23390 dose-dependently (0.1-1.0 mg/kg) reversed cocaine-induced locomotion and occupied 72-100% of D1-like receptors in the anterior NAc. D1 receptor occupancy following systemic administration of SCH-23390 was evident as an inverted U-shaped, dose-dependent change, with the greatest occupancy observed at the intermediate dose of 0.3 mg/kg. Intraaccumbens infusion of SCH-23390 did not alter cocaine-induced locomotor activity despite occupying 40-60% of D1-like receptors in the anterior NAc core and shell. The findings that systemic, but not intraaccumbens, administration of SCH-23390 potently reversed locomotion produced by intraaccumbens cocaine infusion suggest that stimulation of D1 receptors in regions other than the NAc is involved in locomotion produced by intraaccumbens infusion of cocaine, and that stimulation of D1 receptors in the NAc is not necessary for this behavior.

Original languageEnglish (US)
Pages (from-to)194-204
Number of pages11
JournalSynapse
Volume30
Issue number2
DOIs
StatePublished - Oct 1998

Fingerprint

Dopamine D1 Receptors
Locomotion
Cocaine
Nucleus Accumbens
SCH 23390

Keywords

  • Caudate-putamen
  • Cocaine
  • Dopamine D1 recep- tors
  • Localization
  • Locomotor activity
  • N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquino- line
  • Nucleus accumbens
  • Receptor autoradiography
  • Receptor occupancy
  • SCH-23390
  • Sniffing

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology
  • Pharmacology

Cite this

Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion. / Neisewander, Janet; Fuchs, Rita A.; O'Dell, Laura E.; Khroyan, Taline V.

In: Synapse, Vol. 30, No. 2, 10.1998, p. 194-204.

Research output: Contribution to journalArticle

Neisewander, Janet ; Fuchs, Rita A. ; O'Dell, Laura E. ; Khroyan, Taline V. / Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion. In: Synapse. 1998 ; Vol. 30, No. 2. pp. 194-204.
@article{6d13fef833a54c8fbe96194be1e3394e,
title = "Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion",
abstract = "This study examined the effects of both systemic and intraaccumbens administration of SCH-23390 in rats on dopamine D1 receptor occupancy and on locomotor activity produced by intraaccumbens infusion of cocaine. In experiment 1, rats received SCH-23390 (0-1 mg/kg, IP) 15 minutes prior to intraaccumbens infusion of cocaine (0 or 100 μg/side). In experiment 2, rats received coinfusion of SCH-23390 (0-1 μg/side) and cocaine (0 or 100 μg/side) into the nucleus accumbens (NAc). After behavioral testing, receptors occupied by SCH-23390 were quantified by injecting animals with their respective dose of SCH-23390, followed by a systemic injection of the irreversible antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Receptors occupied by SCH-23390, and therefore protected from EEDQ- induced inactivation, were quantified from autoradiograms of sections labeled with 3H-SCH-23390. Systemic administration of SCH-23390 dose-dependently (0.1-1.0 mg/kg) reversed cocaine-induced locomotion and occupied 72-100{\%} of D1-like receptors in the anterior NAc. D1 receptor occupancy following systemic administration of SCH-23390 was evident as an inverted U-shaped, dose-dependent change, with the greatest occupancy observed at the intermediate dose of 0.3 mg/kg. Intraaccumbens infusion of SCH-23390 did not alter cocaine-induced locomotor activity despite occupying 40-60{\%} of D1-like receptors in the anterior NAc core and shell. The findings that systemic, but not intraaccumbens, administration of SCH-23390 potently reversed locomotion produced by intraaccumbens cocaine infusion suggest that stimulation of D1 receptors in regions other than the NAc is involved in locomotion produced by intraaccumbens infusion of cocaine, and that stimulation of D1 receptors in the NAc is not necessary for this behavior.",
keywords = "Caudate-putamen, Cocaine, Dopamine D1 recep- tors, Localization, Locomotor activity, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquino- line, Nucleus accumbens, Receptor autoradiography, Receptor occupancy, SCH-23390, Sniffing",
author = "Janet Neisewander and Fuchs, {Rita A.} and O'Dell, {Laura E.} and Khroyan, {Taline V.}",
year = "1998",
month = "10",
doi = "10.1002/(SICI)1098-2396(199810)30:2<194::AID-SYN9>3.0.CO;2-7",
language = "English (US)",
volume = "30",
pages = "194--204",
journal = "Synapse",
issn = "0887-4476",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion

AU - Neisewander, Janet

AU - Fuchs, Rita A.

AU - O'Dell, Laura E.

AU - Khroyan, Taline V.

PY - 1998/10

Y1 - 1998/10

N2 - This study examined the effects of both systemic and intraaccumbens administration of SCH-23390 in rats on dopamine D1 receptor occupancy and on locomotor activity produced by intraaccumbens infusion of cocaine. In experiment 1, rats received SCH-23390 (0-1 mg/kg, IP) 15 minutes prior to intraaccumbens infusion of cocaine (0 or 100 μg/side). In experiment 2, rats received coinfusion of SCH-23390 (0-1 μg/side) and cocaine (0 or 100 μg/side) into the nucleus accumbens (NAc). After behavioral testing, receptors occupied by SCH-23390 were quantified by injecting animals with their respective dose of SCH-23390, followed by a systemic injection of the irreversible antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Receptors occupied by SCH-23390, and therefore protected from EEDQ- induced inactivation, were quantified from autoradiograms of sections labeled with 3H-SCH-23390. Systemic administration of SCH-23390 dose-dependently (0.1-1.0 mg/kg) reversed cocaine-induced locomotion and occupied 72-100% of D1-like receptors in the anterior NAc. D1 receptor occupancy following systemic administration of SCH-23390 was evident as an inverted U-shaped, dose-dependent change, with the greatest occupancy observed at the intermediate dose of 0.3 mg/kg. Intraaccumbens infusion of SCH-23390 did not alter cocaine-induced locomotor activity despite occupying 40-60% of D1-like receptors in the anterior NAc core and shell. The findings that systemic, but not intraaccumbens, administration of SCH-23390 potently reversed locomotion produced by intraaccumbens cocaine infusion suggest that stimulation of D1 receptors in regions other than the NAc is involved in locomotion produced by intraaccumbens infusion of cocaine, and that stimulation of D1 receptors in the NAc is not necessary for this behavior.

AB - This study examined the effects of both systemic and intraaccumbens administration of SCH-23390 in rats on dopamine D1 receptor occupancy and on locomotor activity produced by intraaccumbens infusion of cocaine. In experiment 1, rats received SCH-23390 (0-1 mg/kg, IP) 15 minutes prior to intraaccumbens infusion of cocaine (0 or 100 μg/side). In experiment 2, rats received coinfusion of SCH-23390 (0-1 μg/side) and cocaine (0 or 100 μg/side) into the nucleus accumbens (NAc). After behavioral testing, receptors occupied by SCH-23390 were quantified by injecting animals with their respective dose of SCH-23390, followed by a systemic injection of the irreversible antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Receptors occupied by SCH-23390, and therefore protected from EEDQ- induced inactivation, were quantified from autoradiograms of sections labeled with 3H-SCH-23390. Systemic administration of SCH-23390 dose-dependently (0.1-1.0 mg/kg) reversed cocaine-induced locomotion and occupied 72-100% of D1-like receptors in the anterior NAc. D1 receptor occupancy following systemic administration of SCH-23390 was evident as an inverted U-shaped, dose-dependent change, with the greatest occupancy observed at the intermediate dose of 0.3 mg/kg. Intraaccumbens infusion of SCH-23390 did not alter cocaine-induced locomotor activity despite occupying 40-60% of D1-like receptors in the anterior NAc core and shell. The findings that systemic, but not intraaccumbens, administration of SCH-23390 potently reversed locomotion produced by intraaccumbens cocaine infusion suggest that stimulation of D1 receptors in regions other than the NAc is involved in locomotion produced by intraaccumbens infusion of cocaine, and that stimulation of D1 receptors in the NAc is not necessary for this behavior.

KW - Caudate-putamen

KW - Cocaine

KW - Dopamine D1 recep- tors

KW - Localization

KW - Locomotor activity

KW - N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquino- line

KW - Nucleus accumbens

KW - Receptor autoradiography

KW - Receptor occupancy

KW - SCH-23390

KW - Sniffing

UR - http://www.scopus.com/inward/record.url?scp=0031815723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031815723&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2396(199810)30:2<194::AID-SYN9>3.0.CO;2-7

DO - 10.1002/(SICI)1098-2396(199810)30:2<194::AID-SYN9>3.0.CO;2-7

M3 - Article

C2 - 9723789

AN - SCOPUS:0031815723

VL - 30

SP - 194

EP - 204

JO - Synapse

JF - Synapse

SN - 0887-4476

IS - 2

ER -